Texto: 
pathology: 
 - cd20 positive small lymphoid cells and plasmacytic cells
 - cd3 less frequent, positive in 1/3 of lymphoid cells
 - cd5, cd10 negative
 - in situ hybridization – monoclonal lambda positive
low grade b-cell lymphoma malt type with plasmacytic differentiation
low grade b-cell lymphoma malt type with plasmacytic differentiation
radiation to eye and orbit
persistence of subretinal deposits

body and head mri unremarkable

lp normal

vitrectomy: scant cells consistent with chronic inflammation.  no cytologic atypia or monoclonal b cell population

no definite response to systemic steroids

variable visual acuity 20/20-20/40

94 weeks

increasing subretinal fluid
is the choroid a primary site for involvement with lymphoproliferative neoplasms?
what is the spectrum of lymphoproliferative neoplasms occurring at that site?


Keywords by value: 
- plasmacytic: 0.21157244217519597
- subretinal: 0.14104829478346398
- malt: 0.11886758500554573
- lymphoproliferative: 0.11529728818451837
- cells: 0.10964629421279992
- monoclonal: 0.10589270154608446
- lymphoid: 0.09668687522762746
- b-cell: 0.08510417380000028
- differentiation: 0.07284541675080293
- hybridization: 0.07052414739173199
- 20/20-20/40: 0.07052414739173199
- neoplasms: 0.06959376488499064
- positive: 0.0665492541668188
- cd3: 0.06173524908238711
- cd5: 0.059433792502772864
- vitrectomy: 0.059433792502772864
- -: 0.05861531067866763
- site: 0.057784187790235246
- cd10: 0.057648644092259185
- lambda: 0.05619007163790755
- cd20: 0.05495686619928948
- cytologic: 0.05495686619928948
- atypia: 0.0538886150582933
- ?: 0.05335807200999211
- grade: 0.05207738868721552
- scant: 0.05134098520934502
- 94: 0.048859745782914306
- lp: 0.04785844063928226
- type: 0.04608998765355057
- persistence: 0.04544019366429879
- 1/3: 0.04445937508756013
- situ: 0.04445937508756013
- deposits: 0.04415745246369735
- acuity: 0.04305224975585082
- spectrum: 0.03955453930446886
- lymphoma: 0.039075178150231774
- occurring: 0.03817973724905559
- low: 0.038018688845862396
- definite: 0.03700690945552058
- variable: 0.036422708375401465
- what: 0.03609162664609863
- population: 0.035670476778215256
- choroid: 0.03488936902170392
- orbit: 0.03443727133959719
- response: 0.034263351446505934
- frequent: 0.03417778913357196
- systemic: 0.03270504484203326
- b: 0.03222421344947562
- steroids: 0.032157823026958056
- visual: 0.03099100801085755
- –: 0.03076564099512398
- inflammation: 0.029069878989395306
- eye: 0.02867527845689529
- increasing: 0.028018499559397687
- pathology: 0.027979187440978256
- involvement: 0.025055509253022534
- less: 0.02315152003458146
- unremarkable: 0.022632531349456485
- radiation: 0.02243400999649869
- body: 0.022202109701512675
- negative: 0.020416961290998993
- primary: 0.02025107410316557
- fluid: 0.019429112836830825
- weeks: 0.019402222055209188
- head: 0.01938881048459117
- chronic: 0.019255917063256
- cell: 0.018465925692651892
- :: 0.018084397055850642
- consistent: 0.016762386150649625
- small: 0.01574860227504895
- mri: 0.01570620683931696
- no: 0.013767106411260832
- that: 0.011807845828470586
- normal: 0.010716899636792808
- at: 0.009262105222653064
- is: 0.00899665245415561
- or: 0.00801218199170966
- to: 0.00683308973508778
- in: 0.006742355682244079
- for: 0.005832865189141721
- ,: 0.004331361048276599
- and: 0.004320216137573243
- with: 0.0037441336348764715
- a: 0.0031727984145488103
- of: 0.0027960912191517225
- the: 0.002211988555258013
- .: 0.0002839962887787702
